Through the acquisition, PTI will gain access to LDA’s lead product, the SIMS 1915+, a helium leak test system that combines its helium leak detection technology with its SIMS software for data collection and analysis.
Packaging Technologies & Inspection (PTI), a US-based package testing equipment company, announced on Dec. 1, 2020 that it has completed its acquisition of Leak Detection Associates (LDA), a manufacturer of helium-based, high sensitivity leak detection systems for the pharmaceutical and biologic industries.
Through the acquisition, PTI will gain access to LDA’s lead product, the SIMS 1915+, a helium leak test system that combines its helium leak detection technology with its SIMS software for data collection and analysis, PTI said in a company press release. Additionally, LDA also offers a line of low temperature add-on options that allow for helium leak testing as low as -140°C for individual package samples.
“We are excited about this opportunity, as we see LDA as the global leader in creative helium solutions for high-risk package integrity testing,” said Oliver Stauffer, CEO of PTI, in the press release. “LDA’s leak detection solutions are widely recognized as a market leader for both cold chain and parenteral container applications. LDA’s helium technology and decades of application expertise coupled with PTI’s global network of technical specialists make this partnership a great opportunity to improve high-risk container quality and patient safety.”
“The entire LDA team is excited about becoming part of the PTI family,” added Brian Mulhall, current CEO of LDA, in the press release. “As a leader in leak testing solutions to the regulated industries, PTI brings a new and larger platform on which the LDA instruments and service programs can grow and expand, and we look forward to working with PTI going forward.”
Source: PTI
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.